Carbohydrate-rich diet for acute intermittent porphyria
Part of Digestive system, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This trial tests whether a diet high in carbohydrates can help treat acute intermittent porphyria (AIP), a condition that can cause attacks of pain and other symptoms. If you have AIP, this study wants to see if eating more carbs can prevent or manage attacks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute intermittent porphyria (AIP).
- You are 18 years old or older.
- You are not pregnant.
- You do not have diabetes.
- You are not taking part in any other clinical research for AIP.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genes may affect acute intermittent porphyria (AIP) in families. You may be asked to share health information and provide urine, blood, or saliva samples to help researchers understand what changes genes can make.
This study follows people with diagnosed porphyria over time to learn more about the condition using past and new lab (biochemical) and genetic (DNA) test results. It may help researchers better understand how porphyrias work and support future care.
This study is a registry (a list) of people diagnosed with acute hepatic porphyria. It helps researchers learn about the condition and track health information over time; it doesn’t test a new drug in the way treatment trials do.
This trial compares starting with an early carbohydrate drink versus a clear liquid diet for people with mild or moderately severe acute pancreatitis. The goal is to see which approach helps recovery and is easier to tolerate.
This trial studies a treatment to prevent recurrence in people with type 1 autoimmune pancreatitis (AIP) who are at high risk. It looks at how well the treatment works and whether it can keep the disease from coming back.
This trial tests if pirfenidone, an anti-scarring drug, can reduce the number of repeat episodes of acute pancreatitis. You may be eligible if you've had two or more pancreatitis attacks at least three months apart and are not having an active attack right now.
Hear when a new Porphyria, Acute Intermittent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.